These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7134396)

  • 21. An MRI/US/x-ray compatible breast localization marker: in vivo evaluation.
    Li Y; Holloway CM; Purcell CM; Wang J; Plewes DB
    Acad Radiol; 2005 Dec; 12(12):1557-66. PubMed ID: 16321745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ROC-analysis in x-ray study of the breast; a comparative study between film and xeromammography].
    John V; Callies R; Hirche H; Parson C; Tonge K; Lenz W
    Onkologie; 1979 Oct; 2(5):193-8. PubMed ID: 395475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical brief: Dye localization of small breast lesion.
    Budge JC; Knight RM
    Rocky Mt Med J; 1978; 75(6):322. PubMed ID: 725442
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of mammotome biopsy: retrospective evaluation.
    Polito R; Gaudino S; Costantini M; Lombardi CP; Romani M; Belli P
    Rays; 2005; 30(1):43-9. PubMed ID: 16022120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Somatic radiation risk in various mammography technics].
    Ewen K; John V; vd Driesch P
    Rontgenpraxis; 1981; 34(12):488-92. PubMed ID: 7323894
    [No Abstract]   [Full Text] [Related]  

  • 26. Xeromammography versus screen-film mammography--pros and cons of the two techniques.
    Sickles EA
    West J Med; 1981 Mar; 134(3):273-4. PubMed ID: 7269562
    [No Abstract]   [Full Text] [Related]  

  • 27. Contact spot xeromammography in the early diagnosis of breast cancer.
    Buchanan JB; Jager RM
    AJR Am J Roentgenol; 1978 Jun; 130(6):1159-62. PubMed ID: 418658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Registered 3-D ultrasound and digital stereotactic mammography for breast biopsy guidance.
    Irwin MR; Downey DB; Gardi L; Fenster A
    IEEE Trans Med Imaging; 2008 Mar; 27(3):391-401. PubMed ID: 18334434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical dosimetry in xeromammography using the low dose system].
    Ciccozzi A; Testa A; Bultrini M; Scoccia GM; Ferrara P
    Radiol Med; 1987 Dec; 74(6):567-8. PubMed ID: 3432616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Optimal conditions for positive and negative xeromammography].
    Mamontov VV; Tutkus IA; Atkochius VB
    Med Tekh; 1981; (4):32-5. PubMed ID: 7278554
    [No Abstract]   [Full Text] [Related]  

  • 31. Dose reduction in xeroradiography of the breast.
    Van De Riet W; Wolfe JN
    AJR Am J Roentgenol; 1977 May; 128(5):821-3. PubMed ID: 404909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of vascularity of the breast: a quantitative approach using xeromammography.
    Raskin MM; Martinez-Lopez M
    Rev Interam Radiol; 1977 Apr; 2(2):93-5. PubMed ID: 866901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Device for facilitating lesion localization in breast biopsies.
    Levinsohn EM
    Radiology; 1991 Nov; 181(2):603-4. PubMed ID: 1924812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammography-guided stereotactic fine needle aspiration cytology of breast lesions.
    Ahmad SS; Akhtar K; Abrari A; Ritanjaya ; Ahmad I; Mansoor T
    Indian J Pathol Microbiol; 2006 Jul; 49(3):330-3. PubMed ID: 17001878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computerized quantification of breast duct patterns.
    Shadagopan A; Alcorn FS; Semmlow JL; Ackerman LV
    Radiology; 1982 Jun; 143(3):675-8. PubMed ID: 7079495
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison between phantoms for quality control in xeromammography].
    Gambaccini M; Cinotti A; Ghedini M; Mazzilli MP; Toti A
    Radiol Med; 1987 Mar; 73(3):236-41. PubMed ID: 3562926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prebiopsy localisation of impalpable breast lesions.
    Hisham AN; Harjit K; Fatimah O; Yun SI
    Med J Malaysia; 2004 Aug; 59(3):402-5. PubMed ID: 15727388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factitious microcalcifications in breast biopsy material: laboratory-induced error by use of tattoo powder for specimen mammography.
    Lager DJ; O'Connor JC; Robinson RA; Brown RC; Urdaneta LF
    J Surg Oncol; 1989 Apr; 40(4):281-2. PubMed ID: 2927141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative development xeroradiography of the breast: doses and clinical indications.
    Keddy RJ; Brebner DM
    Br J Radiol; 1980 Apr; 53(628):325-30. PubMed ID: 7378700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xeromammographic automatic exposure termination.
    Zeman GH; Osterman FA; Rao G; Kirk BG; James AE
    Radiology; 1978 Jan; 126(1):117-20. PubMed ID: 619394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.